title: STAT signaling in different breast cancer sub-types.
abstract: This review summarizes information on expression of Signal Transducer and Activator of Transcription (STAT)s 1, 2, 3, 4, 5a/b and 6 in cancer cells from different human breast cancer sub-types. STAT proteins, especially STATs 1, 3 and 5a/b are expressed in some but not all cancers from all of the different major breast cancer sub-types. However, well-designed studies comparing expression patterns at the protein level in cancer and surrounding stromal cells are still needed to fully examine links with prognosis and therapeutic response. Moreover, it is not yet known if distinct expression patterns of STAT proteins could have dissimilar impacts in different sub-types, especially between the luminal A and B ER+ sub-types and the different TNBC sub-types. Recent data indicating that STAT 5 can be activated secondary to a therapeutic intervention and mediate resistance suggests that expression patterns should not only be examined in pre-treatment but also post-treatment samples from different sub-types.
authors.affiliation: Departments of Oncology, Medicine and Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC 20057, USA; WCU Research Center of Nanobiomedical Science, Dankook University, San 29, Anseo-Dong, Cheonan 330-714, Republic of Korea. Electronic address: paf3@georgetown.edu.
authors.forename: Priscilla A
authors.initials: PA
authors.lastname: Furth
mesh_terms: D001943:Breast Neoplasms / Q000145:classification* / Q000378:metabolism*; D005260:Female; D006801:Humans; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism; D011960:Receptors, Estrogen / Q000378:metabolism; D050791:STAT Transcription Factors / Q000378:metabolism*; D015398:Signal Transduction; D064726:Triple Negative Breast Neoplasms / Q000145:classification / Q000378:metabolism
chemical_list: D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D050791:STAT Transcription Factors
keywords: Breast cancer sub-types; ER; ER+ breast cancer; Estrogen Receptor; HER2; HER2 amplified breast cancer; IL; JAK; Janus Kinase; PI3K; STAT; Signal Transducer and Activator of Transcription; Signal Transducer and Activator of Transcription (STAT); TNBC; Triple Negative Breast Cancer; Triple negative breast cancer; human epidermal growth factor 2; interleukin; mTOR; mammalian target of rapamycin; phosphatidylinositol 3-kinase
references.citation: J Proteomics. 2012 Jun 6;75(10):3031-40
references.pmid: 22178447
references.citation: Br J Cancer. 2012 Sep 4;107(6):947-55
references.pmid: 22892392
references.citation: Histopathology. 2012 Jun;60(7):1125-32
references.pmid: 22320867
references.citation: J Clin Oncol. 2011 Jun 20;29(18):2448-58
references.pmid: 21576635
references.citation: Int J Cancer. 2006 Jun 15;118(12):2943-7
references.pmid: 16425286
references.citation: Int J Cancer. 2009 May 1;124(9):2124-34
references.pmid: 19142869
references.citation: Breast Cancer Res. 2011 Oct 06;13(5):R97
references.pmid: 21978456
references.citation: Breast Cancer Res Treat. 2013 Jan;137(2):417-29
references.pmid: 23242618
references.citation: Proc Natl Acad Sci U S A. 2012 May 15;109(20):7765-9
references.pmid: 22547799
references.citation: Ann Oncol. 2012 Dec;23(12):2997-3006
references.pmid: 23166150
references.citation: Breast Cancer Res. 2010;12(3):R42
references.pmid: 20576095
references.citation: Mod Pathol. 2013 Apr;26(4):485-95
references.pmid: 23222490
references.citation: Acta Histochem. 2012 Nov;114(7):641-6
references.pmid: 22172707
references.citation: Cancer Sci. 2009 Nov;100(11):2028-33
references.pmid: 19659610
references.citation: Clin Cancer Res. 2012 Aug 15;18(16):4465-72
references.pmid: 22711706
references.citation: Front Biosci (Landmark Ed). 2012 Jan 01;17:1232-50
references.pmid: 22201800
references.citation: Breast Cancer Res. 2012 Jan 20;14(1):R16
references.pmid: 22264274
references.citation: Cancer Res. 2006 Jul 15;66(14):7007-15
references.pmid: 16849545
references.citation: Nature. 2012 Oct 4;490(7418):61-70
references.pmid: 23000897
references.citation: Endocr Relat Cancer. 2006 Sep;13(3):885-93
references.pmid: 16954437
references.citation: Int J Cancer. 2004 Feb 20;108(5):665-71
references.pmid: 14696092
references.citation: Carcinogenesis. 2011 Jun;32(6):804-11
references.pmid: 21289371
references.citation: Mol Oncol. 2013 Jun;7(3):379-91
references.pmid: 23228483
references.citation: Am J Pathol. 2004 Nov;165(5):1449-60
references.pmid: 15509516
references.citation: Clin Cancer Res. 2002 Oct;8(10):3065-74
references.pmid: 12374673
references.citation: PLoS One. 2012;7(7):e40531
references.pmid: 22792362
references.citation: J Clin Oncol. 2004 Jun 1;22(11):2053-60
references.pmid: 15169792
references.citation: PLoS One. 2012;7(4):e33361
references.pmid: 22485142
references.citation: Adv Anat Pathol. 2012 Jan;19(1):39-53
references.pmid: 22156833
references.citation: Clin Cancer Res. 2012 Dec 15;18(24):6634-47
references.pmid: 23091114
references.citation: Cytokine. 2008 Apr;42(1):39-47
references.pmid: 18342537
references.citation: Clin Cancer Res. 2006 Jan 1;12(1):20-8
references.pmid: 16397019
references.citation: Int J Oncol. 2008 Jan;32(1):89-95
references.pmid: 18097546
references.citation: J Biol Chem. 2012 Aug 31;287(36):30228-39
references.pmid: 22740693
references.citation: Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):2802-7
references.pmid: 21908711
references.citation: Neoplasia. 2002 Jul-Aug;4(4):324-31
references.pmid: 12082548
references.citation: Cancer Cell. 2012 Dec 11;22(6):796-811
references.pmid: 23238015
references.citation: Cell Cycle. 2012 Jan 15;11(2):367-76
references.pmid: 22189713
references.citation: J Clin Invest. 2011 Oct;121(10):3789-96
references.pmid: 21965335
references.citation: Cancer Treat Rev. 2012 Oct;38(6):698-707
references.pmid: 22178455
references.citation: Breast Cancer Res. 2010;12(5):R85
references.pmid: 20946665
references.citation: Oncologist. 2009 Apr;14(4):320-68
references.pmid: 19346299
references.citation: Mol Oncol. 2011 Feb;5(1):5-23
references.pmid: 21147047
references.citation: Clin Cancer Res. 2003 Feb;9(2):594-600
references.pmid: 12576423
references.citation: Mol Carcinog. 2013 Dec;52(12):959-69
references.pmid: 22693070
references.citation: Anticancer Res. 2007 Jul-Aug;27(4B):2481-6
references.pmid: 17695542
references.citation: Int J Cancer. 2012 Nov 1;131(9):1998-2007
references.pmid: 22328489
references.citation: J Clin Invest. 2011 Jul;121(7):2750-67
references.pmid: 21633166
references.citation: Cancer Res. 1998 May 1;58(9):1914-9
references.pmid: 9581833